Acorda Therapeutics (ACOR) Reports Q2 Loss of $7.55
Tweet
Share
E-mail
Get Alerts ACOR Hot Sheet
Price: $0.66 --0%
Financial Fact:
Total other expense (net): -4.54M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Total other expense (net): -4.54M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Acorda Therapeutics (NASDAQ: ACOR) reported Q2 EPS of ($7.55). Revenue for the quarter came in at $29.68 million.
For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gordon Haskett cuts TJX Companies rating to Accumulate
- Webull Corp (BULL) Tops Q2 EPS by 1c
- Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
